Cystic degeneration /spongiosis hepatis in rats has been proposed to be a preneoplastic and/or neoplastic lesion by some authors, because of its proliferative properties and persistent increased cell turnover rate in stop experiments using hepatocarcinogens , and the assumption that it can develop into a sarcoma. The neoplastic potential of cystic degeneration is questioned in this review article. Cystic degeneration , which appears to derive from altered Ito cells, does not have neoplastic histomorphologi c characteristics, although it may be composed of cells with an increased mitotic index. In this regard, persistent proliferation is also seen with other nonneoplasti c lesions. Argument s are presented to show that the induced, probably extremely rare sarcoma that was associated with cystic degeneration most likely derives from the very rare induced spherical Ito-cell aggregate with an unusually high cellular turnover rate in rats treated with hepatocarcinogens , and not from cystic degeneration . Also, in none of 12 referenced standard oncogenicity studies with chemically induced cystic degeneration was the lesion associated with mesenchymal (Ito-cell) tumors. Consequently, evidence is lacking that cystic degeneratio n in rats should be classi ed as a preneoplastic or neoplastic lesion.
INTRODUCTION
The designation of an induced change seen in animals within a toxicity study as neoplastic or nonneoplasti c carries important implications. A treatment-related degenerative change and many nonneoplastic proliferative events are often of minor concern, when observed at very high dose levels in evaluating the effects of a compound on rodents in an oncogenicity study. However, ascribing an increase in the incidence of a neoplasm to an effect of a compound is usually regarded as a major concern, as it may imply a potential for human carcinogenesis. Therefore, it may become an issue of great importance whether cystic degeneration/spongiosis hepatis in rats is considered to represent a neoplastic change, as postulated by several authors. In this paper, we review the literature available in multiple species regarding this histomorphologic entity and critically evaluate the evidence used to designate suggest that this lesion may occur rarely in other mammals, such as mice (36) or humans (39) . However, there is no doubt that it occurs in teleost sh, especially after treatment with the hepatocarcinogen diethylnitrosamine (11, 13, 14, 16, 17) .
Morphology
The most detailed descriptions of this lesion are given by Bannasch and coworkers, who examined the livers of rats treated with hepatocarcinogens (5, 9) . Accordingly, the lesion "is characterized by cyst-like multilocular formations lled with a nely granular or occulent acidophilic material" of variable size and does not compress adjacent normal or neoplastic liver tissue, but rather replaces it (Figure 1 ). It is important to differentiate this nding from peliosis or teleangiectasis of sinusoids, which are sinusoidal dilatations usually lled with blood, clearly lined by endothelial cells, and often have a more tortuous or sinuous appearance consistent with the vascular origin of this change. The lack of a vascular connection for the cavities of cystic degeneration can be demonstrated by injecting India ink into the portal vein, resulting in no penetration of the dye into such lesions. Occasional erythrocytes, leukocytes, or necrotic hepatocytes observed within the cavities are probably a consequence of breakdown of the cavity walls. The walls of the cavities or pseudocysts are narrow and contain small roundto-elongated nuclei within broblast-like cells, which stain green by Masson-Goldner, are weakly positive following the PAS reaction, contain faint red spots with the van Gieson stain, and are positive with the Gomori silver impregnation stain. By immunohistochemistry the walls are positive for laminin, bronectin, and collagen types III and IV, but not type I. In addition, most cells are positive for desmin and vimentin (5, 9) , whereas only a few stain weakly for a -smooth muscle actin (68) . Walls are not lined by epithelia or endothelia, although in semithin epon sections, a thin lining is observed that does not stain with alcian blue and is negative for iron (5, 9) . Cystic degeneration induced by hepatocarcinogens may be associated with or even part of Ito-cell aggregates, which are not readily recognized in H&E sections, but can be made visible by immunohistochemical demonstration of desmin within the altered Ito cells (68) .
Electron microscopic investigation shows the walls of the cavities to consist of cells resembling broblasts with long cytoplasmic extensions in contact with neighboring cells. They are covered by a basement membrane-like lining about 1.5 l m thick, containing bundles of collagen bers with a regular cross-striation pattern having a periodicity of 53 nm. Evidence for the cellular origin of the at broblast-like cells forming the walls in the lesion is provided by the presence of osmophilic droplets characteristic for Ito cells retained within the cytoplasm of lining cells (5, 9) . In smaller lesions, the cells in question are located in the space of Disse (as are Ito cells) between the hepatocytes and endothelial cells of sinusoids. In larger lesions, this orientation is gradually lost with concomitant loss of hepatocytes (5, 9) .
The granular or occulent acidophilic material within the cavities stains intensely green with Masson-Goldner and is weakly positive after the PAS reaction. It is often alcianophilic and gives a positive iron-binding reaction, suggesting the presence of proteoglycans (5, 9) . Ito cells are known to produce such substances during brogenesis following hepatocellular damage (27, 34) . As lesions become larger, cyst-like cavities con uence through the disappearance of intercavity walls, to form larger pseudocysts that may have diameters above 1 mm. Focal lesions may reach a diameter of 8 mm (5) by growth or by con uence of multiple lesions. Interestingly, even the largest lesions are not known to bulge above the surface of the liver.
The previous description of induced lesions, based on publications by Bannasch and coworkers, appears to apply also to the morphology of spontaneous lesions in the liver of rats. However, spontaneous cystic degeneration is not usually observed during the rst year of life, is less likely to be multiple, and has not been reported to be associated with Ito cell aggregates.
Chemical Induction, Proliferation, and Hypothetical Neoplastic Potential
Cystic degeneration in rats can be induced by continued application of the hepatocarcinogens N -nitrosomorpholine, dimethylnitrosamine, nitrosopyrrolidine , or 2-acetylaminouorene, but not by the bladder carcinogen butylbutanolnitrosamine (4, 5, 9, 42, 69) . Lesions may be observed as early as 40 weeks after the start of treatment and can affect nearly all animals, depending on treatment schedule and duration of the experiment. There can be no doubt that genotoxic hepatocarcinogens inducing hepatocellular neoplasia in rats also cause cystic degeneration; however, the relationship between these events will be examined critically.
In the early 80s, it was speculated that cystic degeneration induced by hepatocarcinogens "might turn out to be a preneoplastic or neoplastic process" (4, 5, 79) . In the mid-80s, the observation was made "that a considerable cell proliferation may appear in spongiotic lesions after very long lag periods," leading to the statement that "some ndings even suggested that spongiosis may progress to a malignant mesenchymal tumor," for which the term pericytoma was proposed (6, 9) . In the mid-90s, desmin staining was used to demonstrate spherical Ito-cell aggregates associated with carcinogen-induced cystic degeneration (8, 69) . It was noted that cystic degeneration can occur with or without the Ito-cell aggregates, and spherical Ito-cell aggregates can occur with and without cystic degeneration. Autoradiographic investigations by the same authors show an increase in the cell turnover rate of Ito cells in both Ito-cell aggregates and cystic degeneration by a factor of 6 when compared to Ito cells in normal liver tissue of controls. Ito-cell aggregates with a massive increase in cellular density (see later) have a considerably higher cell turnover rate. The authors write that "spongiotic formations are an integral part of larger proliferative lesions which show a slowly progressive behavior independent of an ongoing carcinogenic stimulus and should, hence, be regarded as benign neoplasms" (8, 69) . They proposed the term spongiotic pericytoma for this change. Furthermore, they suggested that "malignant mesenchymal tumors that may derive from these lesions should consequently be called perisinusoidal (Ito) cell sarcoma" (7, 8, 69) .
The morphology of cystic degeneration/spongiosis hepatis, with or without Ito-cell aggregates, does not show standard neoplastic characteristics. The lesions do not compress adjacent tissue or bulge above the surface of the liver, but only replace vanishing liver tissue (see Figure 1 ) and are not described to grow larger than 8 mm (5) . Morphologic criteria were not used to suggest that spongiosis hepatis is a preneoplastic, or even a neoplastic lesion. Arguments hinge on its apparently continuous proliferative nature and the assumption that a sarcoma exists that is supposed to derive from cystic degeneration in rats treated with hepatocarcinogens. We do not question the neoplastic nature of a proliferative lesion illustrated (8) ; however, there is no proof that it is derived from cystic degeneration/spongiosis hepatis cells. This sarcoma could be a unique response of the liver to the carcinogen used and has not been reported otherwise in the rat liver, with or without cystic degeneration.
The other argument for the neoplastic nature is based on the observation that the cell turnover of all types of spongiosis hepatis (with or without Ito-cell aggregates) is increased by a factor of 6 (69), even after the treatment with hepatocarcinogens has been stopped. In the same paper, 7 hepatocarcinogen-induce d lesions "with a massive increase in cellular density" of desmin-positive Ito cells are mentioned. Autoradiographic investigations of 2 such lesions reveal cell turnover rates increased by a factor of 78 and 146, respectively, much higher than the factor-of-6 increase mea-sured for the more common cystic degeneration/spongiosis hepatis lesion. Such carcinogen-induced Ito-cell aggregates with a massive increase in cellular density and a high cell turnover rate are likely candidates for preneoplastic lesions, but there is no good reason to consider that cystic degeneration/spongiosis hepatis should be classi ed as such.
It is tempting to assume that an increased cell turnover rate, which cannot be explained by physiologi c growth, regeneration, or repair, is autonomous and thus of preneoplastic or neoplastic nature. However, this assumption is not true for some proliferative, tumor-like lesions usually considered to be nonneoplastic. An example is palmar bromatosis (leading to Dupuytren's contraction in humans), a nodular lesion usually not considered to be neoplastic and not known to progress to a sarcoma (1, 23, 63, 64) . Such lesions, mostly of unknown cause (as is spontaneous cystic degeneration in rats), are formed by continuous increased cell proliferation and local tissue formation. Indeed, in many cases chronic cell proliferation caused by continuous treatment with toxic xenobiotics does not lead to tumor formation (71). Thus, the increased cell turnover rate in hepatocarcinogen-induce d cystic degeneration does not per se indicate preneoplastic or neoplastic potential.
Most textbooks and all diagnostic guides do not classify cystic degeneration in rats as a preneoplastic or neoplastic lesion, and do not mention spongiotic pericytoma in the rat liver (21, 25, 29, 30, 32, 33) . The secondary and/or degenerative character of cystic degeneration is underlined by the statement that it should not be diagnosed when present in a focus of cellular alteration or within a hepatocellular neoplasm (29) . The 6 prior references all use the term cystic degeneration and not spongiosis hepatis, probably to emphasis the degenerative nature of the change, and we concur with this.
Cystic Degeneration/Spongiosis Hepatis in Rat Toxicity/Oncogenicity Studies
To evaluate the strength of the assumption that cystic degeneration is a chemically induced neoplastic or preneoplastic change, a search was made for relevant references to supplement those cited previously. No additional primary publication on the induction of cystic degeneration in rats was found, although 3 studies were identi ed, in which the lesion was induced (see later). A search of the extensive National Toxicology Program (NTP) database (through May 1999) for compounds that induce cystic degeneration was also made. Nine compounds were found in the NTP database that cause a treatment-related increase in cystic degeneration in 2-year rat studies. Pertinent results of the 12 studies (9 oral, 2 inhalation, and 1 dermal) are listed in Tables 1 and 2 .
Interestingly, all 12 compounds cause an increased incidence of cystic degeneration in males. However the incidence in females is only clearly increased by 2 compounds (TR-491, TR-390), whereas the results may be considered equivocal in females for 4 substances (Table 2 ). It is also noteworthy that in control animals, spontaneous cystic degeneration is much more common in males than in females, ranging from 0 to 34% in males and 0 to 6% in females, whereas maximum incidences in treated rats reach 89% in males and 58% in females ( Table 2 ). This marked sex predilection has 1 Inhalation study. 2 No induced hepatocellular neoplasms observed in males, in which cystic degeneration is treatment-related. 3 Dermal study, liver weight increase hypertroph y in oral study. NTP-TR National Toxicology Program Technical Report. not been explicitly reported previously, either for spontaneous or induced cystic degeneration in rats, partly due to the fact that males were used exclusively in several experiments (5, 9) .
Of the 9 compounds identi ed in the NTP database, 4/9 are mutagenic (Ames positive, either with or without S9 activation), 5/9 are clastogenic (counting 1 equivocal) and 6/9 are either mutagenic or clastogenic. Thus, 3/9 compounds that induce cystic degeneration in the NTP database do not show any evidence of genotoxicity in any test performed and reported. Three other compounds that cause cystic degeneration could be found by the additional literature search: dimethylacetamide (48), KBR 3023 (76) , and DEHP (19, 20) ( Table 1 ). Of these 3 compounds, 2 are not shown to be genotoxic, yet no data were available for KBR 3023 (Table 1). In summary, 5/12 compounds that are shown to cause cystic degeneration in rats are not demonstrably genotoxic. Thus, cystic degeneration can be induced without genetic damage to Ito cells, because it is highly unlikely that all of these different compounds are selectively genotoxic to Ito cells.
Of these 5 nongenotoxic compounds, dimethylacetamide and KBR 3023 do not induce any tumors in any organs (48, 76) . Thus, compounds that are not genotoxic and have no primary carcinogenic effect in any tissue can cause cystic degeneration. However, the majority of the compounds in Table 1 do have carcinogenic effects, especially on hepatocytes, which is in line with the results demonstrating that hepatocarcinogens can cause cystic degeneration in rats (5, 9) . All compounds in Table 1 , whether mutagenic or not, carcinogenic or not, induce some sort of effect on the liver, such as hypertrophy/hyperplasia, or other changes such as degeneration or necrosis. In this regard, all 12 compounds in Table 1 cause injury or adaptive changes in the liver (which may also be local and secondary to neoplasia). From this it may be deduced that the cause of cystic degeneration in the liver is not directly related to a genotoxic or carcinogenic potential of a compound; however, there always appears to be an association with other effects on the liver.
In regard to this link between nongenotoxic/noncarcinogenic hepatocellular effects and cystic degeneration, hepatic damage results in Ito-cell activation, proliferation and possibly broplasia (27) . However, it is clear that hepatocellular damage does not always lead to cystic degeneration, and furthermore, all areas of the liver with similar damage or change do not all produce cystic degeneration. This is still a multifocal event, and apart from the general observations made before, it is not clear why this lesion develops. Possibly there may simply be an additional effect of particular compounds to induce the excessive extracellular production of proteoglycans that ll the cavities lined by the Ito cells (9) .
Another intriguing possibility is that the proteoglycan secretion is actually part of the reparative response. In this regard it is critical to remember that in spite of these large cystic spaces, the liver parenchyma is not compressed and the surrounding architecture is not distorted. Thus, there obviously must have been signi cant hepatocellular dropout to accommodate the space occupied by the lesion. If the lesion was destroying hepatocytes as it grew, this scenario should present us with evidence of a lesion showing expansive and compressive growth with a rim of degenerating hepatocytes. However, this is not seen. It is possible that the cystic spaces grow to the size necessary to occupy spaces left by hepatocyte dropout caused by focal damage or the presence of hepatocellular neoplasia. This would be a unique reparative method that would minimize liver function loss in an organ that depends to a large degree on an intact architecture for function. Thus, it may be a combination of hepatic damage that produces local proliferation of Ito cells and subsequent alteration of the Ito-cell metabolism to secrete acid proteoglycans to prevent distortion of the liver due to hepatocellular loss. Whatever the nal etiopathogenesis, it seems that, although cystic degeneration is often associated with hepatic neoplasia, it obviously occurs in the absence of any liver tumors. In addition, it can occur spontaneously, or be induced by administration of compounds that are not genotoxic and from compounds that are not hepatocarcinogens or even carcinogens in any organ. This evidence argues strongly against cystic degeneration being a neoplastic, or even a preneoplastic change and suggests rather that this change is a reparative (certainly proliferative) change of Ito cells, perhaps associated with degeneration and/or functional modulation.
In the 12 studies with induced cystic degeneration, no induction of sarcomas in the liver was observed (Table 1) . Thus, the neoplastic progression suggested by some authors from their experiments (69, 79) was not found, even though almost 4,000 rats were exposed, 1,317 of them with the maximum tolerated dose.
ITO CELLS IN MAMMALS-FUNCTION AND LIVER
PATHOLOGY Recently, there has been considerable research on the cell type originally designated as Ito cells. The current review is not meant to be an exhaustive treatment of all aspects of Ito-cell biology, as the amount of literature in this area is very large. In this review we continue to call these cells by their original name, although the contemporary literature has given a lot of weight to the terms perisinusoidal cell or stellate cell. Ito cells are cited to comprise 15% of the total number of resident hepatic cells, although some sources mention gures as low as 5%, and have a well-recognized role in storage of retinoids (27, 37, 78) .
The current emphasis has been on proliferation of Ito cells in broplasia following a variety of insults to the liver. Following liver damage, Ito cells undergo activation whereby quiescent cells are transformed into a phenotype with new functions including proliferation, brogenesis, and/or contractility (24, 26, 27, 43, 44) . Activation of these cells has been subdivided into a temporal sequence with early events termed initiation and later events termed perpetuation (27) . Initiation is caused by factors produced by injured hepatocytes and from neighboring endothelial cells and macrophages, including Kupffer cells (27, 45) . Perpetuation is caused by increasing levels of cytokines (thought to be mediated mainly through receptor tyrosine kinases), as well as by remodeling of the extracellular matrix (ECM) (26) . In particular, the remodeling of the ECM is pivotal to brogenesis produced by Ito cells and underlies much of the subsequent cellular response to liver injury. There is a gradual replacement of the lowdensity subendothelial matrix with a brillar collagen-rich substrate. This material feeds back via integrin receptors and receptor tyrosine kinases to promote activation/perpetuation of Ito cells (2, 27, 59) .
As the activation of the Ito cells progresses into the perpetuation stage, there are phenotypic alterations to the cells that de ne the response and outcome of liver injury. These alterations have been classi ed as proliferation, contractility, brogenesis, matrix degradation, Ito-cell chemotaxis and leukocyte chemoattraction, retinoid loss, and cytokine release (27) .
Proliferation of Ito cells is mediated by polypeptide growth factors, in particular platelet derived growth factor as well as others including vascular endothelial growth factor and basic broblast growth factor that, in turn, are transduced through protein kinases inducing subsequent calcium-dependent mitogenesis (2, 59) . This proliferation of Ito cells is subsequently resolved by loss of Ito cells due to apoptosis (40) .
With regard to contractility, Ito cells in injured liver have been described to undergo myo broblastic transformation (44, 61, 65, 67) . This is consistent with work that has characterized the appearance of both desmin and a -smooth muscle actin in activated Ito cells (65, 68) . Other markers used to identify Ito cells in culture or tissue section include vimentin, glial brillary acidic protein (GFAP), nestin, laminin, and tenascin (3, 12, 47, 55, 70, 75) . Interestingly, a functional consequence of Ito-cell contractility may be the increase in portal resistance secondary to liver injury (27) . The principal mediator of this contractility appears to be endothelin-1, which also promotes Ito-cell proliferation (60, 66) .
Fibrogenesis in the liver, as with many organs, is a complicated sequence of events, in which Ito cells play a key role. Indeed, one of the principle effects of activation of Ito cells is up-regulation of collagen synthesis, both by transcriptional and posttranscriptional events (27) . Control of this is clearly multifactorial and may be affected by many cytokines among which transforming growth factor beta (TGF-b ) is very important (26) . Experiments with TGF-b 1 knockout mice with experimental liver injury showed markedly diminished brosis, although Ito cells expressed an activated phenotype, indicating that this factor is associated with perpetuation rather than initiation of Ito-cell activity (27, 38) .
Matrix degradation appears to be a delicate balance of protease activation (especially matrix metalloproteinase (MMP)-2, MMP-3/stromelysin) to degrade subendothelial extracellular matrix that promotes replacement by brillar collagen while inhibiting the activation of interstitial collagenases to maintain the brosis (10, 27, 40) . Interestingly, there is a positive feedback loop whereby brillar collagen promotes Ito-cell proliferation and MMP-2 production (72).
Chemotaxis of Ito cells promotes accumulation at sites of cellular injury. This is complex and poorly understood, but requires matrix breakdown (as described previously) to allow movement and is stimulated by a variety of cytokines including platelet-derived growth factor and monocyte chemotactic protein (MCP) (39, 52, 53) . Ito-cell chemotaxis can be inhibited by interferon-gamma (39) . In addition, Ito cells can promote neutrophil and monocyte chemoattraction through release of macrophage colony-stimulating factor and MCP-1 (50, 51, 58) .
Retinoid loss during activation is well known and of unclear consequences. Metabolites of retinoic acid can stimulate the activation of latent TGF-b (27) and thus may promote brogenesis.
Finally, negative feedback of Ito-cell activation may result from soluble cytokines such as IL-10 (27) and interferongamma (67) . Because activated Ito cells produce these factors, it may indicate the presence of a negative feedback loop to control Ito-cell function during liver injury (73, 77) . In addition, the presence of intact normal subendothelial matrix, such as occurs following successful resolution of injury, promotes Ito-cell quiescence (27) .
The mechanisms discussed before leading to Ito-cell transformation and proliferation during brogenesis may in part apply to the formation of the lesions of cystic degeneration.
ITO-CELL TUMORS IN MAMMALS
Tumors derived from Ito cells (also called fat-storing cells) are dif cult to distinguish from other liver tumors with cytoplasmic fat vacuoles. Recently, 8 spontaneous benign Ito-cell tumors were identi ed among 4682 CBA/J mice by the immunohistochemical demonstration of tenascin, in the liver produced only by Ito cells (74) . These tumors are seen at necropsy as pale white areas (2x) or nodules (6x) with diameters from 1 to 15 mm. They can compress adjacent liver parenchyma and are formed by round-to spindle-shaped cells, the more spherical ones containing lipid droplets of various sizes (see Figure 2 ). In the light of these ndings, "lipomatous lesions," suspected to be of Ito-cell origin in mice (22, 28, 35, 36) and rats (25) may also be Ito-cell tumors. Lesions in mice can measure up to 2.5 cm (22) . No dimensions for the rat lesions are given (25) , but one shown is nodular and bulging on the liver surface, with a diameter probably exceeding 1 cm. Lipomatous tumors/myolipomas in the liver of various species may also be Ito-cell tumors, as in a domestic cat (31) , cheetahs and a Siberian tiger (46), a bowhead whale (37) , and man (18, 41, 57, 62) . Thus, there is some evidence that Ito-cell tumors exist, that they are very rare, in mice and rats reach diameters above 1 cm, compress surrounding liver tissue, and bulge above the surface.
These recognized spontaneous Ito-cell tumors are characterized by cytoplasmic fat vacuoles (74) . However, the spongiotic tumor induced by N -nitrosomorpholine and proposed to be derived from Ito cells/cystic degeneration (7, 8, 69) does not appear to have fat vacuoles, and thus lacks an important characteristic phenotype of recognized Ito-cell tumors.
CLASSIFICATION OF PROLIFERATIVE ITO-CELL LESIONS
IN RATS Various Ito-cell phenotypes are known and those associated with proliferation have been described. Accordingly, Ito-cell aggregates; those with the highest cell turnover rate possibly giving rise to a malignant spongiotic tumor (7, 8, 69) .
The relationships between the various Ito-cell phenotypes and possible neoplastic transformation, particularly in relation to cystic degeneration, are worth discussing. Ito-cell activation, including proliferation is well known in the process of brogenesis in the injured liver and very common in man (cirrhosis). The complicated regulation of this process as described here does not lead to the development of sarcomas in the wake of brous cirrhosis, as such neoplasms are not known to follow the progression of this common disease. In this situation, Ito cells in the perpetuation phase of brogenesis (see previous information) show persistent increased cell proliferation without forming neoplasms. Why should Ito cells act differently when forming cystic degeneration in rats and sh? Persistent proliferation alone does not prove the presence of neoplasia (71) .
Two speci c proliferative Ito-cell lesions are worth direct comparison: cystic degeneration with Ito-cell aggregates, also called spongiotic pericytoma, not larger than 8 mm (5, 8, 69) ; and Ito-cell tumors (74) reaching diameters up to 25 mm in mice. Obvious size differences between these lesions are even more evident if one considers that Ito-cell tumors occur singly (25, 74) , yet cystic degeneration is very often multiple (if induced), and the larger lesions of the latter most likely result from the con uence of multiple lesions. Furthermore, con nement of cystic degeneration to the shape of the liver indicates that its growth is not autonomous, but regulated and limited, which is not a feature of expansive neoplastic growth. This is contrasted with the compressive growth and bulging above the organ surface seen in Ito-cell tumors, which is characteristic of neoplastic growth. The regulated and limited growth of cystic degeneration is an additional reason for its classi cation as a nonneoplastic, albeit proliferative, lesion.
CYSTIC DEGENERATION /SPONGIOSIS HEPATIS IN FISH
Fish are the only species other than rats in which a change consistent with cystic degeneration/spongiosis hepatis is well described by various groups (11, 13, 14, 16, 17) . The description of the basic lesion in sh is very similar to that described in rats. Therefore, it seems to be most expedient to concentrate on differences to the lesion in rats, or on features that address the main theme of the current review, that is, whether the known data indicate that this lesion is nonneoplastic, preneoplastic, or neoplastic in sh. A signicant difference between sh and rats is the progression of the classical lesion (see Figure 3 ). Cystic degeneration rapidly progresses in the sheepshead minnow (Cyprinodon variegatus) from relatively small foci at 8 to 14 weeks of age, up to very large foci that may occupy up to 40 to 70% of the surface area of the liver at 43 to 140 weeks of age (16) . Another difference is the expression of markers for Ito cells. A study of hepatocarcinogenesis in Medaka (Oryzias latipes) shows that normal perisinusoidal Ito cells as well as those forming cystic degeneration are negative for actin and desmin, which are described to be a markers for Ito cells in humans and rats (14; see previously). Whereas this may be a function of poor cross-reactivity of mesenchymal cell markers between sh and mammals, this does suggest caution when comparing the 2 lesions in sh and mammals.
Cystic degeneration in sh, as in rats, has been most often described in conjunction with studies of chemically induced hepatocarcinogenesis (13, 14, 16, 17) . Therefore, these authors suggest that this lesion in sh is also a preneoplastic or neoplastic transformation of Ito cells. However, many of the same concerns over this concept in rats are valid in sh with regard to the assertion that this is neoplastic or preneoplastic. For example, it is clear that this lesion can be found in control study animals and older individuals (broodstock), albeit at a low incidence (11, 13) . Thus, chemical administration is not a prerequisite to develop this lesion, which is a similar situation in rats. Furthermore, noncarcinogenic chemicals can cause an increased incidence of this lesion in sh, further loosening the association between carcinogenic chemicals and cystic degeneration in sh (11) .
Although chemicals are known to induce increased incidence and severity of this lesion in sh, it is not clear whether cystic degeneration is caused by the chemicals themselves, or whether it is a consequence of the damage done to the liver, either directly, or indirectly due to expansion of hepatic neoplasia in the vicinity. It was noted in one study that early lesions of cystic degeneration develop in "areas of hepatocellular dropout with perisinusoidal cells attempting to form a structural reparative network" (13) . Furthermore, it is stated in another study using minnows that "early spongiosis hepatis is detectable with light microscopy and appears as a small reticulated focus in regenerating hepatic parenchyma" (17) . This would be consistent with the role of Ito cells in mammals as reparative cells within the liver and consistent with our deduction that chemicals inducing this lesion in rats also affect or damage the parenchyma in some fashion. The subsequent expansion of cystic degeneration to effectively take over the liver in sh as described before is not seen in mammals and may be speci c to sh. Whether or not this larger lesion is neoplastic is still arguable, as there is still little or no compression, and there seems to be hepatocellular dropout accompanying the expansion (13) . This comes down to a determination of whether the Ito cell's proliferative expansion is a reparative response (albeit a large one) as consequence of hepatocellular dropout, or whether it is a neoplastic expansion with subsequent hepatocellular necrosis and loss.
An unusual lesion termed polymorphic cell neoplasm surfaced during a study of the chemical induction of cystic degeneration in the sheepshead minnow (16) . These neoplasms, which had not been described previously, are roughly spherical, highly cellular proliferations of polymorphic spindleshaped cells, which often form swirling patterns within the hepatic parenchyma. In many cases, foci of cystic degeneration were present at the periphery of these clearly malignant neoplasms, suggesting that these two lesions are ontogenetically linked. The author infers the possibility of the unequivocally neoplastic polymorphic cell proliferations being a malignant development from the more benign or preneoplastic cystic degeneration. However, there are some arguments against this hypothesis, some of which are posed by the author himself. First, these lesions are phenotypically very distinct, with the only link being that they are both formed by spindle shaped cells and they often occur adjacent to each other. There is no immunohistochemical way to demonstrate that the cells have a similar precursor and ultrastructurally neither lesion possesses any unique identifying features. Secondly, if the lesions of spongiosis were spawning the malignant neoplasms, which are very proliferative and expansile, it should be expected that the spongiotic foci would predominantly occur within the polymorphic cell neoplasms, rather than at the periphery as described. Third, it is noted that the lesions of cystic degeneration express a uniform and stable phenotype for long periods of time, before being found in conjunction with the malignant neoplasms. The authors themselves suggest the possibility that cystic degeneration is more likely therefore to be a degenerative (and maybe reparative) lesion (16) . We believe that it is likely that cystic degeneration and the polymorphic cell neoplasms develop independently. Although as cystic degeneration may be a consequence of a reparative response by the liver, nding these foci at the periphery of clearly expansile, compressive neoplastic spindle cell proliferations would be appropriate.
It is tempting to speculate on the relationship between the polymorphic cell neoplasms in sh (16) and the spongiotic perisinusoidal cell sarcoma discussed previously in rats (8, 69) . Although they have both been observed associated with cystic degeneration in each species, and may be derived from Ito cells, we have advanced an argument in each case that they are probably not ontogenetically directly related to cystic degeneration. Furthermore, the histomorphology of the polymorphic cell neoplasm of sh (16) appears to be different from that of the "malignant pericytoma" or "perisinusoidal cell sarcoma" of the rat (7) .
In summary, a number of sh species exhibit a similar lesion to cystic degeneration in rats that may occur spontaneously as well as be induced by chemicals that may be carcinogenic or not. Although it has been suggested, by a similar argument used for rats, that this lesion may be classied as neoplastic or preneoplastic, the evidence for this lesion in sh is just as weak as it is in rats.
RISK ASSESSMENT FOR HUMANS
The induction of cystic degeneration of the liver in laboratory rats by a test compound has no direct implication for the risk in humans, because such a lesion does not appear to exist in man: Human Ito cells do not seem capable of forming the lesion "cystic degeneration" as observed in rats.
However, an indirect implication cannot be excluded, because a compound that adversely affected rat Ito cells might lead to corresponding cellular alterations in different human cells or tissues. To include such a hypothetical possibility in the risk assessment, it should be considered whether the alteration induced in rats is nonneoplastic, preneoplastic, or neoplastic in nature.
Based on the previous arguments, cystic degeneration derived from Ito cells in rats should be considered as a speciesspeci c, chronic lesion, markedly different from Ito-cell tumors with fat vacuoles, and not of preneoplastic or neoplastic nature. Risk assessment regarding the increased incidence and severity of cystic degeneration in rats should be done as for other induced nonneoplastic lesions without a counterpart in man, considering no-effect levels and safety margins. SUMMARY AND CONCLUSIONS Cystic degeneration/spongiosis hepatis is a spontaneous liver lesion in aging rats of unknown cause, more common in males than females, usually with a low incidence that on occasion can be as high as 34%. The lesion appears to develop from Ito cells that transform to broblast-like cells, producing extracellular proteoglycans, which ll cavities that may converge into large cystic spaces.
Examination of 12 compounds from the literature and NTP database shows that nongenotoxic, noncarcinogens as well as genotoxic carcinogens can cause cystic degeneration in rats (Table 1 ). It is noteworthy that there is a marked sex predilection in rats with males more likely to develop either spontaneous or chemically induced lesions ( Table 2) . A common feature of all compounds was the capacity to affect or injure the liver in some other way, as well. The fact that nongenotoxic and noncarcinogenic compounds of various chemical classes can induce this lesion argues against classifying cystic degeneration as neoplastic, or even preneoplastic.
Cystic degeneration, induced by genotoxic hepatocarcinogens, can be associated with Ito-cell proliferation made visible by desmin staining. Such foci of Ito-cell proliferation may also exist without spongiotic formations. In all these lesions the turnover rate of Ito cells is increased by a factor of about 6, compared to Ito cells in control livers, even after treatment with hepatocarcinogens had been stopped. This fact is used to underpin the argument that these lesions are neoplastic and can be called spongiotic pericytoma (69) . This argument is dismissed here due to the fact that proliferation alone, even in the face of a lack of an obvious current stimulus, is not suf cient to label a lesion as neoplastic or preneoplastic. For example, persistent Ito-cell proliferation occurs in other settings such as during reparative responses leading to cirrhosis. Furthermore, persistent proliferation of tissue observed after long-term exposure to toxic xenobiotics by no means always leads to neoplastic lesions (71) . More basically, the histomorphology of cystic degeneration lacks neoplastic characteristics, such as compression, in ltration or metastasis, bulging above the surface of the liver, and size of above 8 mm. And what space it does ll is fairly acellular, being mainly made up of extracellular matrix within cystic spaces. Neoplastic lesions called benign and malignant pericytoma or perisinusoidal cell sarcoma are suggested to be derived from cystic degeneration (7, 8) . We do not consider cystic degeneration to be the precursor. Instead, we believe that a likely candidate for the preneoplastic precursor to this very rare neoplasm is the spherical Ito-cell aggregate, with a massive increase of cellular density and an unusually high cell turnover rate, which are not features of cystic degeneration.
It appears that Ito-cell tumors with intracellular fat vacuoles exist in rats and mice, albeit very rarely (25, 74) . These tumors exhibit bulging above the liver surface, diameters considerably larger than 1 cm, and histomorphology consistent with neoplastic growth. These differences between Ito-cell tumors and cystic degeneration further underline the conclusion that cystic degeneration (with or without Ito-cell aggregates) is not a neoplasm.
On the basis of our review of the literature, we suggest that the following proliferative Ito-cell lesions can be differentiated in rats (Table 3): 1. Spontaneous Ito-cell tumors (with cytoplasmic fat vacuoles) 2. Induced liver brosis not leading to sarcomas 3. Spontaneous and induced cystic degeneration not leading to sarcomas 4. Induced Ito-cell aggregates: Those with a massive increase in cellular density and an unusually high cell turnover rate (2 reported) may lead to sarcomas (extremely rare lesion).
Cystic degeneration in sh appears to be homologous to the rat lesion. Arguments for and against the neoplastic nature of the lesion parallel those for the rat lesion. Polymorphic cell neoplasms, highly proliferative, expansile masses, are associated with cystic degeneration in sh treated with hepatocarcinogens. Because there is no evidence that cystic degeneration is a precursor of the previous neoplasm, the lesion should not be called preneoplastic in sh either.
Regarding risk assessment for man, induced cystic degeneration in a rat oncogenicity study would not imply a direct toxic or carcinogenic risk, if one considers that the lesion does not occur in humans. Furthermore, considering the conclusion that cystic degeneration is not a preneoplastic or neoplastic lesion in rats or sh, the assessment for a potential indirect risk in man can be based on no-effect levels and safety margins, as with other nonneoplastic adverse effects that have no counterpart in man.
